Impax Laboratories, Inc. v. Federal Trade Commission
Filed: April 13, 2021
State: United States
Court: US Court of Appeals, Fifth Circuit
Case Number: 19-60394
NEW YORK HOTEL TRADES COUNCIL V. IMPAX LABORATORIES, INC.
Filed: January 11, 2021
State: United States
Court: US Court of Appeals, Ninth Circuit
Case Number: 19-16744
IMPAX LABORATORIES, INC. v. ZYDUS PHARMACEUTICALS USA, INC. et al
Filed: March 23, 2020
State: New Jersey
Court: New Jersey District Court
Case Number: 2:2017cv13476
OPINION and ORDER denying 196 Defendants' Motion in Limine; denying 198 Plaintiff's Motion in Limine. etc. Signed by Judge Stanley R. Chesler on 3/24/2020. (dam, )
Williams v. Impax Laboratories, Inc.,
Filed: November 8, 2019
State: California
Court: Court of Appeal
Case Number: A155479
IMPAX LABORATORIES, INC. v. ZYDUS PHARMACEUTICALS USA, INC. et al
Filed: July 25, 2019
State: New Jersey
Court: New Jersey District Court
Case Number: 2:2017cv13476
OPINION AND ORDER; The Court concludes that Plaintiff is correct and that the phrase, "a controlled release oral solid formulation of levodopa," has its ordinary meaning.. Signed by Judge Stanley R. Chesler on 7/25/2019. (ld, )
IMPAX LABORATORIES, INC. v. ZYDUS PHARMACEUTICALS USA, INC. et al
Filed: December 6, 2018
State: New Jersey
Court: New Jersey District Court
Case Number: 2:2017cv13476
ORDER granting 104 MOTION to Redact and Seal Transcript/Digital Recording re: 89 Transcript. Signed by Magistrate Judge Cathy L. Waldor on 12/6/2018. (gl, )
IMPAX LABORATORIES, INC. v. ZYDUS PHARMACEUTICALS USA, INC. et al
Filed: November 29, 2018
State: New Jersey
Court: New Jersey District Court
Case Number: 2:2017cv13476
OPINION. Signed by Judge Stanley R. Chesler on 11/29/2018. (dam, )
Impax Laboratories, Inc. v. Turing Pharmaceuticals AG
Filed: November 6, 2018
State: New York
Court: New York Southern District Court
Case Number: 1:2016cv03241
AMENDED OPINION AND ORDER re: 112 MOTION for Reconsideration: For the reasons set forth above, Impax's motion is GRANTED in part and DENIED in part. (Signed by Judge Edgardo Ramos on 11/6/2018) (jwh)
Impax Laboratories, Inc. v. Turing Pharmaceuticals AG
Filed: August 21, 2018
State: New York
Court: New York Southern District Court
Case Number: 1:2016cv03241
OPINION AND ORDER re: 118 LETTER MOTION for Oral Argument addressed to Judge Edgardo Ramos from Daniel H. Weiner dated Oct. 27, 2017 filed by Turing Pharmaceuticals AG, 111 LETTER MOTION for Oral Argument regarding Motio n for Clarification and/or Reconsideration addressed to Judge Edgardo Ramos from James E. Brandt dated October 13, 2017 filed by Impax Laboratories, Inc., 112 MOTION for Reconsideration re; 110 Memorandum & Opinion -- Moti on for Clarification and/or Reconsideration of…
IMPAX LABORATORIES INC. v. LANNETT HOLDINGS INC.
Filed: July 2, 2018
State: United States
Court: US Court of Appeals, Federal Circuit
Case Number: 17-2020
IMPAX LABORATORIES INC. v. LANNETT HOLDINGS INC.
Filed: June 28, 2018
State: United States
Court: US Court of Appeals, Federal Circuit
Case Number: 17-2020
IMPAX LABORATORIES, INC. v. ACTAVIS LABORATORIES FL, INC. et al
Filed: April 18, 2018
State: New Jersey
Court: New Jersey District Court
Case Number: 2:2015cv06934
AMENDED OPINION/ORDER that Actavis motion for summary judgment of noninfringement (Docket Entry No. 142), pursuant to Federal Rule of Civil Procedure 56), is GRANTED in part and DENIED in part. Signed by Judge Stanley R. Chesler on 4/18/18. (DD, )
IMPAX LABORATORIES, INC. v. ACTAVIS LABORATORIES FL, INC. et al
Filed: March 8, 2018
State: New Jersey
Court: New Jersey District Court
Case Number: 2:2015cv06934
OPINION/ORDER granting in part and denying in part 142 Motion for Summary Judgment; that Actavis is barred from using its two-range calculation theory as adefense against infringement of the claims with a 40% fluctuation limitation. Signed by Judge Stanley R. Chesler on 3/8/18. (DD, )
IMPAX LABORATORIES, INC. v. ACTAVIS LABORATORIES FL, INC. et al
Filed: May 9, 2017
State: New Jersey
Court: New Jersey District Court
Case Number: 2:2015cv06934
OPINION/ORDER re: construction of claims in U.S. Patent No. 8,377,474 (the 474 patent). Signed by Judge Stanley R. Chesler on 5/9/17. (DD, )
Impax Laboratories Inc. et al v. Lannett Holdings Inc. et al
Filed: March 29, 2017
State: Delaware
Court: Delaware District Court
Case Number: 1:2014cv00984
TRIAL OPINION. Defendants have failed to prove the Dearn patents are invalid. If desired, Defendants should request an opportunity to cross-examine Ms. Allen within one week. If Defendants do not make that request, the parties should submit an agreed upon form of final judgment within two weeks. Signed by Judge Richard G. Andrews on 3/29/2017. (nms)
Impax Laboratories, Inc. v. Turing Pharmaceuticals AG
Filed: November 16, 2016
State: New York
Court: New York Southern District Court
Case Number: 1:2016cv03241
OPINION AND ORDER. For the foregoing reasons, Defendant's motion to dismiss with prejudice Plaintiff's unjust enrichment claim (Count V of the Amended Complaint) is GRANTED. Plaintiff's motion for oral argument is DENIED as moot. The C lerk of the Court is respectfully directed to terminate the motions, Doc. 60 & 65. It is SO ORDERED. re: 60 MOTION to Dismiss Plaintiff's Unjust Enrichment Claim. filed by Turing Pharmaceuticals AG, 65 LETTER MOTION for Oral Argument…
ENDO PHARMACEUTICALS INC. v. IMPAX LABORATORIES, INC.
Filed: October 25, 2016
State: New Jersey
Court: New Jersey District Court
Case Number: 2:2016cv02526
OPINION. Signed by Judge Jose L. Linares on 10/25/16. (DD, )
IMPAX LABORATORIES, INC. v. ACTAVIS LABORATORIES FL, INC. et al
Filed: May 27, 2016
State: New Jersey
Court: New Jersey District Court
Case Number: 2:2015cv06934
OPINION/ORDER granting in part and denying in part 43 Motion to Stay; that Impax shall provide the Court with status updates regarding the ex parte reexamination of U.S. Patent No. 7,094,427, every sixty (60) days starting June 17, 2016; that Impax shall notify the Court within ten (10) days of any disposition of the ex parte reexamination of U.S. Patent No. 7,094,427. Signed by Judge Stanley R. Chesler on 5/26/16. (DD, )
linus Aruliah v. Impax Laboratories, Inc. et al
Filed: December 21, 2015
State: California
Court: California Northern District Court
Case Number: 3:2014cv03673
ORDER APPROVING SETTLEMENT AND FINAL JUDGMENT signed by Hon. James Donato on December 21, 2015. (jdlc1S, COURT STAFF) (Filed on 12/21/2015)
Impax Laboratories Inc. et al v. Lannett Holdings Inc. et al
Filed: December 1, 2015
State: Delaware
Court: Delaware District Court
Case Number: 1:2014cv00984
MEMORANDUM OPINION providing claim construction for disputed terms in U.S. Patent Nos. 6,750,237 and 7,220,767. Within five days the parties shall submit a proposed order consistent with this Memorandum Opinion. Signed by Judge Richard G. Andrews on 12/1/2015. (nms)
